Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Daniel J. Kafafian, Acting Special Agent in Charge
New Jersey
@DEANewJerseyDiv
December 04, 2019
Contact: Timothy P. McMahon
Phone Number: (571) 776-1150
For Immediate Release

Former Bordentown physician charged with narcotics distribution and fraud

MOUNT HOLLY, N.J. – DEA New Jersey Division Special Agent in Charge Susan A. Gibson and Burlington County Prosecutor Scott Coffina announced today that narcotics distribution and fraud charges have been filed accusing a former physician of illegally prescribing thousands of highly addictive opioid pills out of his Bordentown Township practice while simultaneously engaging in an unlawful medical billing scheme.

Morris “Moishe” Starkman, 60, of Yellowstone Road in Cinnaminson, was charged with eight counts of distribution of a controlled dangerous substance (second degree), four counts of healthcare claims fraud (second degree) and two counts of insurance fraud (second degree).

He was taken into custody Nov. 22 following the execution of a search warrant at his home, during which multiple electronic devices were seized, along with business, financial and medical records. Starkman was released following a first appearance in Superior Court. The case is being prepared for presentation to a grand jury for possible indictment.

The investigation revealed that between Jan. 1, 2015, and Jan. 1, 2018, Starkman issued prescriptions through his Bordentown family practice for nearly 1,400,000 total doses of opioids, including oxycodone (OxyContin, Percocet, Roxicodone, Endocet), hydrocodone

(Vicodin, Norco, Lorcet, Lortab), oxymorphone (Opana), hydromorphone (Dilaudid), morphine and fentanyl. One patient alone was prescribed 17,460 doses, which equates to more than 15 per day.

Starkman would perform, at most, cursory examinations on patients before prescribing large amounts of opioids without medical justification, consideration of whether his patients were benefitting from the prescription painkillers he routinely and repeatedly prescribed, or exploration of the underlying causes for their pain. He also maintained inadequate records on his patients which failed to document treatment plans for pain management or opioid use, or provide a legitimate medical purpose for prescribing such high quantities for an extended period of time.

“Physicians need to understand that they will be held accountable if they choose to violate the oath they took to help those in need,” said Special Agent in Charge Gibson. “Indiscriminate prescribing of opioids has contributed to the current epidemic the country is facing today. DEA and our law enforcement partners will continue to pursue those drug traffickers who choose to poison our communities.”

“He was one of the top prescribers in New Jersey,” Prosecutor Coffina said. “The number of opioids he prescribed for the three-year period reviewed during the investigation was enough to provide in excess of three doses to every man, woman and child residing in Burlington County.”

The investigation also showed that Starkman submitted fraudulent health care claims to insurance companies for over $50,000 for services that were unauthorized, not eligible for reimbursement, not provided as represented or not rendered.

The State Board of Medical Examiners temporarily suspended Starkman’s license in August 2017. Under a consent order reached in April 2018, Starkman agreed to permanently surrender his license to practice medicine in New Jersey.

The case was investigated by the Drug Enforcement Administration’s Camden Office of Diverison Control and the BCPO Gang, Gun and Narcotics Task Force, with assistance from the New Jersey Division of Consumer Affairs Enforcement Bureau, the New Jersey Division of Criminal Justice, Horizon Blue Cross Blue Shield Special Investigations and the National Insurance Crime Bureau.    

# # #

 

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster